Tag: Idiopathic Pulmonary Fibrosis (IPF) Drugs Market Size

Idiopathic Pulmonary Fibrosis (IPF) Drugs Market size was valued at USD 3.25 Billion in 2022 and is projected to reach USD 7.10 Billion by 2030, growing at a CAGR of 10.6% from 2024 to 2030. Exploring the Idiopathic Pulmonary Fibrosis (IPF) Drugs Market: Trends, Key Insights, and Future Prospects Idiopathic Pulmonary Fibrosis (IPF) is a […]